C

Cardiovascular Research of Northwest Indiana, LLC | Munster, IN

Research site
(Unclaimed)
Location
10010 Donald S Powers Drive, Munster, Indiana, United States of America

Site insights

Top conditions

Top treatments

Obicetrapib
Bococizumab
Olezarsen
Triglycerides
Tirzepatide
Aldosterone
Ezetimibe
LY3298176
Pemafibrate
Empagliflozin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in particip...

Active, not recruiting
Hypertriglyceridemia
Cardiovascular Diseases
Drug: Placebo
Drug: Olezarsen

The main purpose of this study is to assess the efficacy and safety of Tirzepatide (LY3298176) in participants with heart failure with preserved ejec...

Active, not recruiting
Heart Failure With Preserved Ejection Fraction (HFpEF)
Obesity
Other: Placebo
Drug: Tirzepatide

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Obicetrapib
Drug: Placebo

The study is a placebo-controlled, double-blind, randomized, phase 3 study in participants with heterozygous familial hypercholesterolemia (HeFH) and...

Enrolling
Dyslipidemias
Hypercholesterolemia
Other: Combination Therapy placebo
Other: Ezetimibe Placebo

Trial sponsors

N
Pfizer logo
ZOLL Medical logo
Abbott logo
Boehringer Ingelheim logo
Ionis Pharmaceuticals logo
Kowa logo
Lilly logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems